GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lifecome Biochemistry Co 002868.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

18.57

-0.27%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Lifecome Biochemistry Co

Its shares trade on Shenzhen under the ticker 002868.SZ. It has been listed since 3 May 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥516.6m and a net loss of CN¥139.3m. At that date it held total assets of CN¥748.7m and shareholders' equity of CN¥63.2m.

Lifecome Biochemistry Co., Ltd. engages in the manufacture of microbial pharmaceutical products. The company is headquartered in Nanping, Fujian. The company went IPO on 2017-05-03. The firm's businesses include the production and sales of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives and biological pesticide. Its products include bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series and Jinggangmycin series. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
3 May 2017
Employees
788

Leadership

Pay as last reported

  • Mr. Tanping LaiChairman of the Board, General Manager, Acting Secretary of the Board, since 2009CN¥445,300
  • Mr. Zhongshou BaoChief Financial OfficerCN¥228,300
  • Ms. Jing YangDeputy General Manager, Director, since 2021CN¥337,900
  • Mr. Hui HuangDeputy General ManagerCN¥378,900
  • Mr. Junhui LiDeputy General ManagerCN¥244,100
  • Mr. Shiping JiangDirector
  • Mr. Jiumin LaiDirectorCN¥85,900
  • Ms. Yang DiIndependent Director
  • Ms. Shuang WangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Lifecome Biochemistry produces bacitracin and colistin sulfate products for veterinary use.
  • The company employs 788 full-time employees in Nanping, Fujian.
  • Lifecome's product line includes Bacillus subtilis and Bacillus licheniformis for animal health.

Weaknesses

  • Lifecome's veterinary premixes are limited to domestic market distribution.
  • The company has no presence in international markets beyond current overseas sales.
  • Lifecome's product range lacks human pharmaceutical applications.

Opportunities

  • Expanding veterinary soluble powders into Southeast Asian markets.
  • Increasing sales of biological pesticides in the Chinese agricultural sector.
  • Growing demand for food additives in the domestic Chinese market.

Threats

  • Competition from domestic biotechnology firms in China.
  • Regulatory changes affecting veterinary raw materials in China.
  • Rising costs of feed additives in the global market.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.